Lorenz, Carolin http://orcid.org/0000-0002-7202-6061
Gaigl, Gabriele
Güler, Duygu
Halms, Theresa
Khorikian-Ghazari, Naiiri
Röh, Astrid
Schneider, Marco
Wagner, Elias
Schneider-Axmann, Thomas
Kapfhammer, Angelika
Flick, Marisa
Pielenz, Charline
Salveridou-Hof, Eva
Falkai, Peter
Gaebel, Wolfgang
Hasan, Alkomiet
Leucht, Stefan
Funding for this research was provided by:
Gemeinsame Bundesausschuss (01VSF20024)
Technische Universität München
Article History
Received: 6 July 2022
Accepted: 14 September 2022
First Online: 24 September 2022
Declarations
:
: The trial has been performed according to the latest version of the Declaration of Helsinki [CitationRef removed]. The trial has been approved in ethical and legal terms by the local ethics committee of the medical faculty of the LMU, Munich (reference number 21-0780), and the involved data protection officer (reference number 1819.b.). All participants have accepted and signed the written informed consent.
: Not applicable.
: C. Lorenz: none. G. Gaigl: none. D. Güler: none. T. Halms: none. N. Khorikian-Ghazari: none. A. Röh: none. M. Schneider: none. E. Wagner: none. T. Schneider-Axmann: none. A. Kapfhammer: none. M. Flick: none. C. Pielenz: none. E. Salveridou-Hof: none. P. Falkai received research support/honoraria for lectures or advisory activities from: Abbott, Boehringer-Ingelheim, Janssen, Essex, Lundbeck, Otsuka, Recordati, Richter, Servier and Takeda. He holds a payed position as chairman of the Psychiatric Department of the University Munich and is full professor at the Psychiatric Department of the University Munich. He has received and is currently receiving grants from several national and international foundations and institutions, e.g., from the “German Science Foundation,” the “German Ministry of Science,” and the “German Ministry of Health.” W. Gaebel is a member of the Lundbeck International Neuroscience Foundation. A. Hasan has been invited to scientific meetings by Lundbeck, Janssen-Cilag, and Pfizer, and he received paid speakerships from Janssen, Recordati, Otsuka, and Lundbeck. He was a member of Roche, Otsuka, Lundbeck, Rovi, Recordati, and Janssen advisory boards. S. Leucht reported personal fees from Alkermes, Angelini Pharma, Eisai, Gedeon Richter, Janssen Pharmaceuticals, Johnson & Johnson, Lundbeck, Medichem, Merck Sharp & Dohme, Otsuka Pharmaceutical, Casen Recordati, Rovi, Sandoz, Sanofi, Sunovion, Teva Pharmaceuticals, Boehringer Ingelheim, and LTS Lohmann.